- /C O R R E C T I O N -- Nanalysis Scientific Corp./
- Nanalysis Announces Full Year 2023 Conference Call
- Nanalysis Scientific Corp. Announces Director Resignation
- Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances
- NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT
- Canadian Investment Regulatory Organization Trading Halt - NSCI
- NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT
- Nanalysis Announces Upcoming Webinar and Conference Participation
- Nanalysis Achieves Record Revenue in Q4
- Nanalysis Scientific Corp. Provides Update on Security Services Business
More ▼
Key statistics
As of last trade, Nanalysis Scientific Corp (NSCI:CVE) traded at 0.44, 27.54% above the 52 week low of 0.345 set on Mar 18, 2024.
52-week range
Open | 0.45 |
---|---|
High | 0.45 |
Low | 0.44 |
Bid | 0.44 |
Offer | 0.445 |
Previous close | 0.45 |
Average volume | 95.48k |
---|---|
Shares outstanding | 111.72m |
Free float | 104.48m |
P/E (TTM) | -- |
Market cap | 50.11m CAD |
EPS (TTM) | -0.1748 CAD |
Data delayed at least 15 minutes, as of Apr 26 2024 16:29 BST.
More ▼